Clover Health Investments, Corp. — Form 8-K Summary
Business Context and Reporting Period
Clover Health Investments, Corp. filed a Form 8-K dated May 26, 2022, under Item 5.02. The filing reports a change to the Company’s board of directors. It is not a periodic financial report.
Board Change
- Nathaniel S. Turner resigned as a member of Clover’s Board of Directors effective May 26, 2022.
- The filing states that the resignation was not due to any disagreement with the Company regarding its operations, policies, or practices.
- Management recognized Turner’s contributions, including his role in Clover’s founding and his service on the Board for approximately six years.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes, Outlook, and Risks
The material change disclosed is the departure of a director. The filing does not provide updated guidance, an outlook, management forecasts, contingencies, or new risk disclosures.
Key Facts for Investors to Verify
- Confirm the effective date and circumstances of Nathaniel S. Turner’s board resignation.
- Review subsequent filings for any board replacement, committee reassignment, or changes to corporate governance.
- Consult the Company’s periodic reports for financial performance, liquidity, debt, guidance, and risk information, which are not included in this filing.